Product cited in:
Solier, Sordet, Kohn, Pommier: "Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways." in: Molecular and cellular biology, Vol. 29, Issue 1, pp. 68-82, 2008 (PubMed).
Ito, Yoshida, Matsuzuka, Matsuura, Nakamura, Nakamine, Kakudo, Kuma, Miyauchi: "Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation." in: International journal of molecular medicine, Vol. 13, Issue 3, pp. 431-5, 2004 (PubMed).
Nemoto, Vogt, Oguri, Lazo: "Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cells." in: The Prostate, Vol. 58, Issue 1, pp. 95-102, 2003 (PubMed).
Goloudina, Yamaguchi, Chervyakova, Appella, Fornace, Bulavin: "Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint." in: Cell cycle (Georgetown, Tex.), Vol. 2, Issue 5, pp. 473-8, 2003 (PubMed).
Chow, Siu, Fung, Chan, Lau, Arooz, Ng, Yamashita, Poon: "DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase." in: Molecular biology of the cell, Vol. 14, Issue 10, pp. 3989-4002, 2003 (PubMed).
Chen, Ryan, Piwnica-Worms: "Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding." in: Molecular and cellular biology, Vol. 23, Issue 21, pp. 7488-97, 2003 (PubMed).